Drug Shortage Report for TOBREX

Last updated on 2019-09-06 History
Report ID 87200
Drug Identification Number 00614254
Brand name TOBREX
Common or Proper name TOBREX OINT 3.5G
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) 3MG
Dosage form(s) OINTMENT
Route of administration OPHTHALMIC
Packaging size 3.5G
ATC code S01AA
ATC description ANTIINFECTIVES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-06-27
Actual start date 2019-06-20
Estimated end date 2019-09-10
Actual end date 2019-09-05
Shortage status Resolved
Updated date 2019-09-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-06-21 English Compare
v2 2019-06-21 French Compare
v3 2019-07-08 English Compare
v4 2019-07-08 French Compare
v5 2019-07-26 English Compare
v6 2019-07-26 French Compare
v7 2019-09-05 English Compare
v8 2019-09-05 French Compare
v9 2019-09-06 English Compare

Showing 1 to 9 of 9